HOME >> BIOLOGY >> NEWS
Tiny molecules have big potential as cancer drugs, Stanford researcher believes

PHILADELPHIA Many cancer therapies take a "big stick" approach, targeting rapidly dividing cells in the body to stop malignancies in their tracks but often triggering horrible side effects in the process. New research from the Stanford University School of Medicine points toward the possibility of a different type of cancer drug small molecules that would home in on the proteins tumors need without poisoning patients.

Matthew Bogyo, PhD, assistant professor of pathology, will discuss his studies of some of these molecules at an Aug. 24 talk during the "Genomic Approaches to Enzymology" session of the American Chemical Society's national meeting in Philadelphia.

Previous studies have shown that an increase of certain proteins, called cathepsin cysteine proteases, is associated with tumor development. "People have shown that more of the cathepsins are present in cancers and that they appear to be secreted by cancer cells," said Bogyo. "The question is what are they doing and does it help to block them?" To find out, Bogyo and colleagues used fluorescent tags to track cathepsin activity in mouse models of two types of cancer. They found the cathepsins helped build blood vessels to the tumors as well as increase tumor growth and invasiveness.

The team also tried giving a broad-spectrum cathepsin inhibitor to some cancerous mice and found that it slowed tumor development both in early and late stages of growth with no apparent side effects. The National Cancer Institute has since fast-tracked the inhibitor into studies of toxicity and pharmacodynamics as a potential drug. Meanwhile the research group has used the compound as a jumping-off point, testing similar compounds to find those that bind specifically to "problem" cathepsins, instead of to all of them. Bogyo is also looking for additional molecules that have better potency and pharmacodynamic properties.

Bogyo will give details on tests of some of these molecules at his presentatio
'"/>

Contact: Mitzi Baker
mitzibaker@stanford.edu
650-725-2106
Stanford University Medical Center
24-Aug-2004


Page: 1 2

Related biology news :

1. Synthesized molecules studied as weapon to stop cell division in cancer cells
2. Scientists reinvent DNA as template to produce organic molecules
3. Sweet success in targeting sugar molecules to cells in living animals
4. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
5. Scientists pinpoint molecules that generate synapses
6. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
7. Controlling biomolecules with magnetic tweezers
8. Water molecules clump more loosely than previously thought
9. Creating polymers that act like biomolecules
10. A new way to see DNA (and other tiny molecules)
11. St. Jude shows how disorderliness in some proteins lets them interact with a diversity of molecules

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 12, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced that ... biologics business. Dr. Schaffer has played an integral advisory role on the gene ...
(Date:9/8/2019)... Calif. (PRWEB) , ... September 06, 2019 , ... ... Board of Directors of Nanosens Innovations have each authorized the respective companies to ... a subsidiary of Cardea, with the Nanosens brand representing a series of products ...
(Date:8/27/2019)... ... ... Shoreline Biome , a microbiome research company that develops tools for characterizing ... and Karen Woodward as its VP of Business Development. , These two new ... expand the company’s sales worldwide. , Prior to joining Shoreline Biome, Bill McKenzie was ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was just a puppy ... was limping and lame on his right hip and elbow. At one year of ... “the worst case the vet had seen.” He was prescribed pain medications, both oral ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global ... Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO ... , After a careful process of evaluation, twelve companies out of over 200 ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson ... focused on how best to characterize 3D cell culture models. The inherent problem of ... too thick and opaque to image through and therefore traditional wide-field or even confocal ...
(Date:8/29/2019)... ... August 29, 2019 , ... ... affecting grapevines, a feat they hope will ultimately help protect the multibillion-dollar grape ... several Rochester Institute of Technology faculty and alumni sequenced the microbiome found within ...
Breaking Biology Technology:
Cached News: